Kantonsspital St.Gallen
login

publications

Markus Glatzer

title  
 
Kroeze S G C, Schaule J, Fritz C, Kaul D, Blanck O, Kahl K H, Roeder F, Siva S, Verhoeff J J C, Adebahr S, Schymalla M M, Glatzer M, Szuecs M, Geier M, Skazikis G, Sackerer I, Lohaus F, Eckert F, Guckenberger M. Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the 'TOaSTT' database. Radiat Oncol 2021; 16:4.
   
Süveg K, Putora P M, Joerger M, Iseli T, Fischer G F, Ammann K, Glatzer M. Radiotherapy for thymic epithelial tumours: a review. Transl Lung Cancer Res 2021; 10:2088-2100.
   
Fleischmann M, Glatzer M, Rödel C, Tselis N. Radioimmunotherapy: future prospects from the perspective of brachytherapy. J Contemp Brachytherapy 2021; 13:458-467.
   
Glatzer M, Leskow P, Caparrotti F, Elicin O, Furrer M, Gambazzi F, Dutly A, Gelpke H, Guckenberger M, Heuberger J, Inderbitzi R, Cafarotti S, Karenovics W, Kestenholz P, Kocher G J, Kraxner P, Krueger T, Martucci F, Oehler C, Ozsahin M, Papachristofilou A, Wagnetz D, Zaugg K, Zwahlen D, Opitz I, Putora P M. Stage III N2 non-small cell lung cancer treatment: decision-making among surgeons and radiation oncologists. Transl Lung Cancer Res 2021; 10:1960-1968.
   
Süveg K, Le Pechoux C, Faivre-Finn C, Putora P M, De Ruysscher D, Widder J, Van Houtte P, Troost E G C, Slotman B J, Ramella S, Pöttgen C, Peeters S T H, Nestle U, McDonald F, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Glatzer M. Role of Postoperative Radiotherapy in the Management for Resected NSCLC - Decision Criteria in Clinical Routine Pre- and Post-LungART. Clin Lung Cancer 2021; 22:579-586.
   
Iseli T, Berghmans T, Glatzer M, Rittmeyer A, Massard G, Durieux V, Buchsbaum T, Putora P M. Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy. ERJ Open Res 2020; 6:.
   
Glatzer M, Horber D, Montemurro M, Winterhalder R, Inauen R, Berger M, Pestalozzi B, Pederiva S, Pless M, Putora P M. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20 (2020):686-690.
   
Glatzer M, Horber D, Montemurro M, Winterhalder R, Inauen R, Berger M D, Pestalozzi B, Pederiva S, Pless M, Putora P M. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20:686-690.
   
Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D, Galateau-Salle F, Greillier L, Hoda M A, Klepetko W, Lacourt A, McElnay P, Maskell N A, Mutti L, Pairon J C, Van Schil P, Van Meerbeeck J P, Waller D, Weder W, Cardillo G, Putora P M. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J 2020; 55:.
   
Opitz I, Scherpereel A, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Fennell D A, Galateau-Salle F, Greillier L, Hoda M A, Klepetko W, Lacourt A, McElnay P, Maskell N A, Mutti L, Pairon J C, Van Schil P, Van Meerbeeck J P, Waller D, Weder W, Putora P M, Cardillo G. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur J Cardiothorac Surg 2020; 58:1-24.
   
Iseli T, Fischer G, Panje C, Glatzer M, Hundsberger T, Rothermundt C, Schmidt B, Sirén C, Plasswilm L, Putora P M. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
   
Glatzer M, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost E G C, Dahele M R, Slotman B J, Ramella S, Pöttgen C, Peeters S T H, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Putora P M. Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise. Radiother Oncol 2020; 150:26-29.
   
Glatzer M, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost E G C, Slotman B J, Ramella S, Pöttgen C, Peeters S T H, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Süveg K, Putora P M. Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine. Radiother Oncol 2020; 154:269-273.
   
Hundsberger T, Schoser B, Leupold D, Rösler K M, Putora P M. Comparison of recent pivotal recommendations for the diagnosis and treatment of late-onset Pompe disease using diagnostic nodes-the Pompe disease burden scale. J Neurol 2019; 266:2010-2017.
   
Putora P M, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, De Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, Brien M O, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman B J. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019; 135:74-77.
   
Putora P M, Glatzer M, De Ruysscher D, Faivre-Finn C, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, De Marinis F, Dziadiuszko R, Felip E, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O' Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, Slotman B J. Erratum to "Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts" [Radiother. Oncol. 135 (2019) 74-77]. Radiother Oncol 2019; 141:332.
   
Steffen T, Putora P M, Hübner M, Gloor B, Lehmann K, Kettelhack C, Adamina M, Peterli R, Schmidt J, Ris F, Glatzer M. Diagnostic Nodes of Patient Selection for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Among Colorectal Cancer Patients: A Swiss National Multicenter Survey. Clin Colorectal Cancer 2019; 18:e335-e342.
   
Garelli E, Rittmeyer A, Putora P M, Glatzer M, Dressel R, Andreas S. Abscopal effect in lung cancer: three case reports and a concise review. Immunotherapy 2019; 11:1445-1461.
   
Putora P M, Glatzer M, Belderbos J, Besse B, Blackhall F, Califano R, Cappuzzo F, De Marinis F, Dziadziuszko R, Felip E, Faivre-Finn C, Früh M, Garrido P, Le Pechoux C, McDonald F, Nestle U, Novello S, O'Brien M, Paz Ares L, Peeters S, Pöttgen C, Ramella S, Reck M, Slotman B, Troost E G C, Van Houtte P, Westeel V, Widder J, Mornex F, De Ruysscher D. Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts. Radiother Oncol 2019; 133:163-166.
   
Panje C, Zilli T, Pra A D, Arnold W, Brouwer K, Garcia Schüler H I, Gomez S, Herrera F, Khanfir K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D, Putora P M. Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice. Radiat Oncol 2019; 14:177.
   
Putora P M, De Ruysscher D, Glatzer M, Widder J, Van Houtte P, Troost E G C, Slotman B J, Ramella S, Pöttgen C, Peeters S, Nestle U, McDonald F, Le Pechoux C, Dziadziuszko R, Belderbos J, Faivre-Finn C. The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. Radiother Oncol 2019; 145:45-48.
   
Panje C, Höng L, Hayoz S, Baracos V E, Herrmann E, Garcia Schüler H, Meier U R, Henke G, Schacher S, Hawle H, Gérard M A, Ruhstaller T, Plasswilm L, Swiss Group For Clinical Cancer Research (SAKK) . Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. Radiat Oncol 2019; 14:166.
   
Scheithauer W, Putora P M, Grünberger B, Eisterer W, Wöll E, Prager G, Schaberl-Moser R, Greil R, Glatzer M. Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine. Therap Adv Gastroenterol 2019; 12:1756284819877635.
   
Süveg K, Putora P M, Berghmans T, Glatzer M, Kovac V, Cihoric N. Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry. Lung Cancer 2018; 124:12-18.
   
Glatzer M, Putora P M. Der Einsatz der Radiotherapie beim kleinzelligen Lungenkarzinom: Update 2018. Schweizer Zeitschrift für Onkologie (SZO) 2018; 1:11-13.
   
Radovic M, Kanesvaran R, Rittmeyer A, Früh M, Minervini F, Glatzer M, Putora P M. Multidisciplinary treatment of lung cancer in older patients: A review. J Geriatr Oncol 2018; 10:405-410.
   
Glatzer M, Panje C, Siren C, Cihoric N, Putora P M. Decision Making Criteria in Oncology. Oncology 2018; Sep 18:1-9:.
   
Vasiljevic D, Arnold C, Neuman D, Fink K, Popovscaia M, Kvitsaridze I, Nevinny-Stickel M, Glatzer M, Lukas P, Seppi T. Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study. Strahlenther Onkol 2018; 194:520-532.
   
Cihoric N, Tsikkinis A, Vlaskou Badra E, Glatzer M, Novak U, Aebersold D, Lössl K. Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study. Radiation Oncology 2017;.
   
Cihoric N, Tsikkinis A, Vlaskou Badra E, Glatzer M, Novak U, Scherz A, Shelan M, Soldatovic I, Yojena C K K, Aebersold D M, Lössl K. Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study. Radiat Oncol 2017; 12:202.
   
Glatzer M. Hot topics from the Assemblies - Review QUARTZ trial. Breathe 2017;1-2.
   
Glatzer M, Schmid S, Radovic M, Früh M, Putora P M. The role of radiation therapy in the management of small cell lung cancer. Breathe (Sheff) 2017; 13:e87-e94.
   
Panje C, Glatzer M, Von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora P M. Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Med Res Methodol 2017; 17:123.
   
Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora P M. Treatment of limited disease small cell lung cancer: the multidisciplinary team. Eur Respir J 2017; 50:.
   
Dal Pra A, Panje C, Zilli T, Arnold W, Brouwer K, Garcia H, Glatzer M, Gomez S, Herrera F, Kaouthar K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen D R, Engeler D, Putora P M. Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice. Strahlenther Onkol 2017; 194:9-16.
   
Glatzer M, Putora P M, Plasswilm L. Radioimmuntherapie – die neue Strategie im Kampf gegen Krebs? Wirkprinzipien, Therapiekonzepte und (prä-)klinische Studiendaten. SZO 2016;.
   
Putora P M, Szentesi K, Glatzer M, Rodriguez R, Müller J, Baty F, Früh M. SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer. Oncol Res Treat 2016; 39:681-686.
   
Glatzer M, Elicin O, Ramella S, Nestle U, Putora P M. Radio(chemo)therapy in locally advanced nonsmall cell lung cancer. Eur Respir Rev 2016; 25:65-70.
   
Glatzer M, Putora P M. Radiochemotherapie beim lokal fortgeschrittenen NSCLC - Update 2015. SZO 2015; 4:18-22.
   
Nowosielski M, Glatzer M, Beer R, Maier H, Stockhammer G. A 39-Year-Old Patient with Double Vision and Rapidly Progressing Bulbar Palsy. European Association of NeuroOncology Magazine 2011; 1:35-36.
   
Glatzer M, Putora P M, Müller J, Minervini F, & Plasswilm L (2016). Case report: radio-supersensitive oligometastatic lung cancer. In .
   
 
page 1 of 1